Cerus Corporation (NASDAQ:CERS) headquartered in Concord, will host a conference call for the investment community to discuss the 2Q20 earnings result on 4th August 2020 at 4:30 PM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.cerus.com
Earnings Expectation
Cerus Corporation developer of biomedical products, is reporting second quarter earnings results on Tuesday 4th August 2020, after market close. The consensus estimates from Thomson Reuters are loss of $ 0.11 per share. For the full year, analysts predict revenues of $ 112.80 million, while looking forward to loss of $ 0.42 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 89.00 million ~ $ 93.00 million
Click Here For More Historical Outlooks Of Cerus Corporation
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; and INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion.
